The University of California, Irvine has launched a new Center for Neurotherapeutics to facilitate drug discovery for neurological diseases.
The center will focus on building a drug discovery unit and therapy delivery program to support research aimed at uncovering new medicines to treat neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, along with muscular dystrophies and motor neuron disorders.
“We are incredibly excited to create a program that will enable researchers from a variety of disciplines to come together with the goal of advancing scientific discoveries made at UCI into transformative therapies for conditions that, for the most part, are currently untreatable,” said Albert LaSpada, Distinguished Professor of pathology, neurology and biological chemistry, as well as associate dean for research development at the UCI School of Medicine.
The new center will be led by Dr. LaSpada and Robert Spitale, professor and associate dean of research at the UCI School of Pharmacy & Pharmaceutical Sciences.
What is Neurotherapeutics?
In case you were wondering, neurotherapeutics is defined as “the study and development of therapeutic agents that target the nervous system.”
Neurotherapeutics is the study of how to prevent, diagnose and treat neurological disorders. It encompasses a wide range of disciplines, including neuroscience, pharmacology, psychiatry, and psychology.
LAStartups.com is a digital lifestyle publication that covers the culture of startups and technology companies in Los Angeles. It is the go-to site for people who want to keep up with what matters in Los Angeles’ tech and startups from those who know the city best.